Korro Bio, Inc. (KRRO)

USD 44.46

(-10.65%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - 14.06 Million 36.98 Million 28.94 Million -
Cost of Revenue 3.63 Million 2.51 Million 3.84 Million 1.58 Million 16.81 Million 654 Thousand
Gross Profit -3.63 Million -2.51 Million 10.22 Million 35.4 Million 12.13 Million -654 Thousand
Operating Expenses 84.53 Million 58.99 Million 35.49 Million 62.95 Million 32.8 Million 18.29 Million
Selling, General and Administrative Expenses 27.28 Million 16.79 Million 11.68 Million 26.29 Million 14.47 Million 6.71 Million
Research and Development Expenses 57.25 Million 42.2 Million 23.8 Million 36.65 Million 18.33 Million 11.58 Million
Other Expenses - 976 Thousand 13.53 Million - - -
Cost and Expenses 84.53 Million 58.99 Million 35.49 Million 64.53 Million 49.62 Million 18.94 Million
Operating Income -84.53 Million -58.99 Million -35.49 Million -27.55 Million -20.67 Million -18.94 Million
Interest Expense - 118 Thousand - - - 106 Thousand
Income Tax Expense 27 Thousand 10 Thousand 2000.00 35 Thousand - -
Earnings before Tax -81.14 Million -58.02 Million -21.95 Million -26.47 Million -18.74 Million -19.16 Million
Net Income -81.17 Million -58.03 Million -21.95 Million -26.51 Million -18.74 Million -19.16 Million
Earnings Per Share Basic -53.08 -227.58 -4.94 -41.10 -30.39 -30.57
Earnings Per Share Diluted -53.08 -227.42 -4.94 -41.10 -30.39 -30.57
Weighted Average Shares Outstanding 1.52 Million 255 Thousand 4.44 Million 645.06 Thousand 616.89 Thousand 627.08 Thousand
Weighted Average Shares Outstanding (Diluted) 1.52 Million 255.17 Thousand 4.44 Million 645.06 Thousand 616.89 Thousand 627.08 Thousand
Gross Margin - - 0.73 0.96 0.42 -
EBIT Margin - - -2.41 -0.70 -0.69 -
Profit Margin - - -1.56 -0.72 -0.65 -
EBITDA -80.9 Million -56.48 Million -33.89 Million -24.89 Million -17.93 Million -18.4 Million
Earnings Before Tax Margin - - -2.52 -0.74 -0.71 -

Income Statement Charts